FdaApplication

NDA 210557

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCOSETTE PHARMACEUTICALS INC
application_typeNDA
approval_date2019-06-21

Products (1)

ProductActive ingredientStrengthDosage form
VYLEESI (AUTOINJECTOR)BREMELANOTIDE ACETATEEQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML)SOLUTION;SUBCUTANEOUS

1 product